I've been reading through some announcements and about the company, all very promising. I would be grateful if someone could give me some quick insight into the progress of clinical trials and perhaps a rough timeline. Also are we likely to get news next week of the DSMB's review or do you think we'll only hear about it after cohort 5?
- Forums
- ASX - By Stock
- BLT
- Fair value
Fair value, page-18
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)